A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome

American Journal of Gastroenterology

Volumn 113, Issue 9, 2018, Pages 1290-1300

  Dionne, Joanna ^a   Ford, Alexander C ^b,c   Yuan, Yuhong ^a   Chey, William D ^d   Lacy, Brian E ^e   Saito, Yuri A ^f   Quigley, Eamonn M M ^g   Moayyedi, Paul ^a,h  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e MAYO CLINIC   (United States)

^f MAYO CLINIC   (United States)

^g HOUSTON METHODIST HOSPITAL   (United States)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; CLINICAL EFFECTIVENESS; DISEASE EXACERBATION; ELIMINATION DIET; EVIDENCE BASED MEDICINE; GLUTEN FREE DIET; HUMAN; IRRITABLE COLON; LOW FODMAP DIET; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC); DIET THERAPY; FERMENTATION; LOW CARBOHYDRATE DIET; METABOLISM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

DISACCHARIDE; GLUTEN; MONOSACCHARIDE;

CLINICAL TRIALS AS TOPIC; DIET, CARBOHYDRATE-RESTRICTED; DIET, GLUTEN-FREE; DISACCHARIDES; FERMENTATION; GLUTENS; HUMANS; IRRITABLE BOWEL SYNDROME; MONOSACCHARIDES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85050676433     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/s41395-018-0195-4     Document Type: Review

References (27)

1. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150:1393–407
2. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–21
3. Pintos-Sanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan DG, et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol. 2015;110:1038–48
4. Palsson, OS, Whitehead, WE, van Tilburg, MA, Chang, L, Chey, W, Crowell, MD, et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016;150:1481–91. 10.1053/j.gastro.2016.02.014
5. Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. American College of Gastroenterology Monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109:S1–S26
6. Lahner E, Bellentani S, de Bastiani R, Tosetti C, Cicala M, Esposito G et al. A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders. United European Gastroenterol J. 2013;1:385–93
7. Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63:108–11
8. Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108:634–41
9. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53:1459–64
10. Verdu E, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. Am J Gastroenterol. 2009;104:1587–94
11. Krogsgaard LR, Lyngesen M, Bytzer P. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome. Aliment Pharmacol Ther. 2017;45:1506–13
12. Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41:1256–70
13. Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. The effect of dietary intervention on irritable bowel syndrome: a systematic review. Clin Transl Gastroenterol.2015;6:e107
14. Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, et al. A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology. 2017;153:936–47
15. Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US with IBS-D. Am J Gastroenterol. 2016;111:1824–32
16. GRADEpro. [Computer program on www.gradepro.org]. Version [v20160405]. McMaster University, 2016
17. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, et al. Gluten causes of gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo controlled trial. Am J Gastroenterol. 2011;106:508–14
18. Shahhbazkhani B, Sadeghi A, Malekzadeh R, Khatavi F, Etemadi M, Kalantri E, et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo controlled trial. Nutrients. 2015;7:4542–54
19. Bohn L, Storsrud S, Liljebo T, Collin L, Lindfors P, Tornblom H, et al. Diet low in FODMAPs reduces symptoms of Irritable Bowel Syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149:1399–407
20. McIntosh K, Reed DE, Schneider T, Dang F, Keshteli AH, De Palma G, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomized controlled trial. Gut. 2017;66:1241–51
21. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146:67–75
22. Staudacher HM, Lomer MCE, Anderson JL, Barret JS, Muir JG, Irving PM, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510–8
23. Hustoft, TN, Hausken, T, Ystad, SO, Valeur, J, Brokstad, K, Hatlebakk, JG, et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motilit 2017;29 10.1111/nmo.12969
24. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed short-chain carbohydrates. Gastroenterology. 2013;145:320–8
25. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6
26. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence - imprecision. J Clin Epidemiol. 2011;64:1283–93
27. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–63